AIMC Topic: Remission Induction

Clear Filters Showing 41 to 42 of 42 articles

A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer.

Indian journal of cancer Jan 1, 2017
INTRODUCTION: The present study for biosimilar trastuzumab was a multicentric, randomized, two-arm parallel-group, comparative phase III study in patients with metastatic breast cancer.
Humans Female Aged Adult Breast Neoplasms Middle Aged India Antineoplastic Combined Chemotherapy Protocols Remission Induction Biosimilar Pharmaceuticals Drug-Related Side Effects and Adverse Reactions Paclitaxel Disease-Free Survival Receptor, ErbB-2 Trastuzumab
View on PubMed DOI

[A Case of Gastric Cancer with Multiple Liver Metastases Treated with XP Chemotherapy and RFA Resulting in a Complete Response for a Long Time].

Gan to kagaku ryoho. Cancer & chemotherapy Nov 1, 2015
A 60-year-old man underwent total gastrectomy with Japanese D2 lymph node dissection for advanced gastric cancer. The resected specimen was diagnosed as well-differentiated tubular carcinoma, pT3, pN1, cM0, and the final stage was considered as ⅡB. D...
Humans Stomach Neoplasms Male Middle Aged Time Factors Liver Neoplasms Antineoplastic Combined Chemotherapy Protocols Gastrectomy Cisplatin Remission Induction Catheter Ablation Capecitabine
View on PubMed
Popular Topics
Recent Journals